ASO Therapy for Solid Tumors

Antisense oligonucleotide (ASO) therapy for two independent targets, GREB1 and ARL4C genes.

Cell based therapy for vascular regeneration

Vascular endothelial stem cells (VESCs) based therapy is a promising approach for vascular regenerat…

Complete Reverse Genetics Rotavirus

Excellent Vaccine Development/Research Platform

CKAP4-targeted Cancer Therapy, mAb treatment

Humanized Anti-CKAP4 mAbs Obtained

Neuro-protectant Peptides for Ischemic Stroke

Fragmentation of RANKL Eliminates Side-effect while Boosting Effect.

Periostin hAbs for Triple Negative Breast Cancer, Other Diseases with ...

Investment / Co-development Opportunity for Start-up Company

Monoclonal Antibody for Diabetes Complications

Variant Specific Periostin Neutralization for Diabetic Retinopathy

Antibodies for the treatment of autoimmune diseases that inhibit the s...

A new therapeutic mechanism to inhibit cytokine production from topical IL-17-producing cells by CD9…

Anti-CD155 antibody treatment for Th1 type autoimmune diseases

Treatment of immunological diseases by a new mechanism to control the immune Th1/Th2 balance

Treatment of heterotopic ossification in patients with fibrodysplasia ...

New therapeutic targets and therapeutic agents for trauma-induced heterotopic ossification in FOP pa…